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Abstract
Fungicide	 resistance	 is	 a	 constant	 threat	 to	 agricultural	 production	 worldwide.	
Molecular	mechanisms	of	fungicide	resistance	have	been	studied	extensively	 in	the	
wheat	pathogen	Zymoseptoria tritici.	However,	 less	is	known	about	the	evolutionary	
processes	driving	resistance	development.	In	vitro	evolutionary	studies	give	the	op-
portunity	to	investigate	this.	Here,	we	examine	the	adaptation	of	Z. tritici	to	fluxapy-
roxad,	 a	 succinate	 dehydrogenase	 (Sdh)	 inhibitor.	 Replicate	 populations	 of	 Z. tritici 
derived	from	the	sensitive	isolate	IPO323	were	exposed	to	increasing	concentrations	
of	fluxapyroxad	with	or	without	UV	mutagenesis.	After	ten	increases	in	fungicide	con-
centration,	sensitivity	had	decreased	dramatically,	with	replicate	populations	showing	
similar	 phenotypic	 trajectories.	 Sequencing	 the	 Sdh	 subunit	 B,	 C,	 and	 D	 encoding	
genes	identified	seven	mutations	associated	with	resistance	to	fluxapyroxad.	Mutation	
frequency	over	time	was	measured	with	a	pyrosequencing	assay,	revealing	sequential	
lineage	replacement	in	the	UV-	mutagenized	populations	but	not	in	the	untreated	pop-
ulations.	Repeating	selection	from	set	time-	points	with	different	fungicide	concentra-
tions	 revealed	 that	 haplotype	 replacement	 of	 Sdh	 variants	 was	 driven	 by	
dose-	dependent	selection	as	fungicide	concentration	changed,	and	was	not	mutation-	
limited.	These	findings	suggest	that	fungicide	field	applications	may	select	for	highly	
insensitive	Sdh	variants	with	higher	resistance	factors	if	the	fungicide	concentration	is	
increased	to	achieve	a	better	disease	control.	However,	in	the	absence	or	presence	of	
lower	fungicide	concentrations,	the	spread	of	these	strains	might	be	restricted	if	the	
underlying	Sdh	mutations	carry	fitness	penalties.
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1  | INTRODUCTION
Populations	 require	 genetic	 variability	 to	 adapt	 to	 new	 environ-
ments	 or	 toxicants.	As	well	 as	 natural	 standing	 variation	 (Barrett	 &	
Schluter,	 2008;	 Hawkins	 et	al.,	 2014),	 genetic	 variability	 can	 arise	
from	de	novo	mutations	(Lenski,	2004;	Torriani,	Brunner,	McDonald,	
&	 Sierotzki,	 2009).	The	mutation	 frequency	 and	 the	 order	 in	which	
beneficial	mutations	accumulate	can	drive	the	evolutionary	adaptation	
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of	 pathogens	 to	 toxicants	 (Cowen	 et	al.,	 2000;	Weinreich,	 Delaney,	
Depristo,	&	Hartl,	 2006).	 Laboratory	 evolution	 studies	 give	 the	 op-
portunity	 to	 investigate	 the	 process	 of	 adaptation	 to	 new	 selective	
pressures	including	toxicants.	Lenski,	Rose,	Simpson,	and	Tadler	(1991)	
founded	a	 long-	term	evolution	experiment	 from	a	 single	Escherichia 
coli	bacterium	in	1988	to	characterize	the	dynamics	of	adaptive	evo-
lution	 over	 long-	term	 periods	 under	 a	 constant	 environment.	 Since	
then,	12	replicate	E. coli-	derived	populations	have	been	evolving	for	
over	 60,000	 generations	 (Cooper,	 Rozen,	 &	 Lenski,	 2003;	 Cooper,	
Schneider,	 Blot,	 &	 Lenski,	 2001;	 Lenski	 &	Travisano,	 1994;	Woods,	
Schneider,	Winkworth,	 Riley,	 &	 Lenski,	 2006).	 Keeping	 a	 “fossil	 re-
cord”	in	the	form	of	glycerol	stocks	of	intermediate	generations	of	the	
E. coli-	derived	populations	allowed	the	experimental	evolution	to	be	
repeated	from	specific	time-	points.	This	enabled	investigation	into	the	
repeatability	of	evolution	under	different	 conditions	and	 the	 role	of	
chance	mutations	(Blount,	Borland,	&	Lenski,	2008).
Studies	 examining	 the	 evolution	 of	 resistance	 to	 toxicants	 have	
found	parallel	 increases	 in	resistance	between	replicate	populations.	
Cowen	et	al.	(2002)	reported	parallel	evolution	of	resistance	to	fluco-
nazole	after	330	generations	in	four	replicate	populations	of	Candida 
albicans.	 Resistance	 was	 conferred	 by	 overexpression	 of	 either	 an	
ATP-	binding	cassette	(ABC)	transporter	or	a	multidrug	major	facilitator	
(MFS)	transporter	encoding	gene.	Similarly,	resistance	to	fluconazole	
in Saccharomyces cerevisiae	was	also	found	to	be	conferred	by	overex-
pression	of	two	ABC	transporters	(pdr5 or snq2)	after	400	generations	
in	replicate	populations	subjected	to	increasing	concentrations	of	the	
fungicide	(Anderson	et	al.,	2003).	Toprak	et	al.	(2012)	also	found	par-
allel	 development	of	 resistance	 in	12	 replicate	populations	of	E. coli 
after	 approximately	 20	days	 under	 an	 increasing	 concentration	 of	
antibiotics.	 Resistance	was	 conferred	 by	 combinations	 of	mutations	
in	three	distinct	genes	or	by	accumulation	of	mutations	in	one	single	
gene.	However,	none	of	the	previous	studies	provided	insights	into	the	
evolutionary	process	of	adaptation	to	fungicides.	This	study	extends	
this	experimental	evolutionary	approach	to	 investigate	the	selection	
process	of	resistance	to	a	new	class	of	fungicides	in	a	plant	pathogen.
Zymoseptoria tritici,	the	causal	agent	of	Septoria	leaf	blotch	(SLB)	
in	wheat,	 is	a	highly	adaptable	 fungal	pathogen	 (Zhan	&	McDonald,	
2004).	This	plant	pathogen	has	developed	resistance	or	reduced	sen-
sitivity	to	fungicides	with	different	mode	of	action,	including	methyl-	
benzimidazole	 carbamates	 (MBCs)	 (Griffin	&	 Fisher,	 1985),	 quinone	
outside	inhibitors	(QoIs)	(Amand	et	al.,	2003;	Fraaije	et	al.,	2005),	and	
sterol-	demethylation	 inhibitors	 (DMIs)	 (Clark,	2006;	Cools	&	Fraaije,	
2013).	Therefore,	options	for	the	chemical	control	of	SLB	are	currently	
limited.	 Since	 2003,	 a	 new	 generation	 of	 succinate	 dehydrogenase	
inhibitor	 (SDHI)	 fungicides	 (e.g.,	 boscalid,	 isopyrazam,	 bixafen,	 pen-
thiopyrad,	and	fluxapyroxad)	with	strong	activity	against	SLB	has	been	
launched	 in	 the	crop	protection	market	 (Fraaije	et	al.,	 2012;	Scalliet	
et	al.,	 2012).	 SDHI	 fungicides	 target	 the	protein	 succinate	dehydro-
genase	 (Sdh),	 also	 known	 as	 succinate	 ubiquinone	 oxidoreductase,	
that	consists	of	four	subunits.	SdhA	oxidises	succinate	to	fumarate	as	
a	component	of	 the	 tricarboxylic	 acid	cycle	 (TCA),	which	 is	 coupled	
with	 the	 reduction	 of	 ubiquinone	 to	 ubiquinol	 as	 part	 of	 the	mito-
chondrial	 electron	 transport	 chain	 (Iverson,	 2013).	The	SDHIs	 exert	
their	 fungicidal	action	by	physically	blocking	the	ubiquinone-	binding	
pocket,	formed	by	Sdh	subunits	B,	C,	and	D	(Ulrich	&	Mathre,	1972).
Laboratory	 studies	using	 single	 generation	exposures	 to	different	
SDHIs	have	reported	several	target-	site	mutations	conferring	reduced	
sensitivity	 in	 mutants	 of	 Z. tritici	 and	 other	 plant	 pathogens	 (Fraaije	
et	al.,	 2012;	 Scalliet	 et	al.,	 2012;	 Sierotzki	 &	 Scalliet,	 2013;	 Skinner	
et	al.,	 1998).	 The	 SDHI	 sensitivity	 can	 be	 differentially	 affected	 by	
	mutations.	For	example,	SdhB-	H267Y	mutants	of	Z. tritici are insensi-
tive	 to	boscalid	but	hypersensitive	 to	 fluopyram.	Other	mutations	of	
laboratory	 mutants,	 such	 as	 SdhB-	H267L,	 SdhC-	N86K,	 and	 SdhD-	
D129G,	confer	high	levels	of	resistance	to	all	SDHIs,	including	fluopy-
ram.	Due	 to	 the	 resistance	 risk,	 the	SDHIs	are	used	 in	mixtures	with	
azoles	or	multisite	inhibitors	at	recommended	rates	to	delay	fungicide	
resistance	development	in	Z. tritici	(FRAC,	2015).	Field	monitoring	stud-
ies	 conducted	 since	2003	 first	 detected	 sensitivity	 changes	 in	 2012.	
Between	 2012	 and	 2015,	 five	 different	 Sdh	 variants,	 SdhB-	N225T,	 
B-	T268I,	C-	T79N,	C-	W80S,	and	C-	N86S,	were	reported	at	low	frequen-
cies	in	France,	Germany,	Ireland	and	the	UK	(FRAC,	2016).	These	Sdh	
variants	display	 low	levels	of	 insensitivity,	and	control	of	SLB	has	not	
been	affected	so	far.	However,	this	may	change	as	field	strains	carry-
ing	C-	H152R,	showing	high	resistance	factors	to	SDHIs	in	vitro,	have	
recently	been	detected	in	Ireland	(Dooley,	Shaw,	Mehenni-	Ciz,	Spink,	&	
Kildea,	2016)	and	the	UK	(B.	A.	Fraaije,	unpublished),	albeit	at	low	levels.
Insensitivity	to	SDHIs	has	evolved	in	Z. tritici	field	populations	as	
predicted	 from	 the	 variants	 found	 in	 laboratory	 mutational	 experi-
ments.	However,	the	extent	of	fitness	penalties	associated	with	mu-
tations	 in	the	target	protein	conferring	resistance	to	SDHIs,	and	the	
functional	constrains	affecting	Sdh	evolution	under	SDHI	field	selec-
tion	where	populations	are	exposed	to	different	dose	rates	and	spray	
frequencies	remain	unknown.	In	vitro	evolutionary	studies	enabling	to	
accelerate	the	evolution	give	the	opportunity	to	investigate	this.
In	this	study,	we	determined	the	course	of	evolution	of	resistance	
to	the	Sdh	 inhibitor	 fluxapyroxad	 in	replicate	populations	of	Z. tritici 
generated	 from	 the	SDHI	 sensitive	 reference	 isolate	 IPO323	 (Kema	
&	van	Silfhout,	1997).	The	IPO323	derived	populations	were	exposed	
to	increasing	inhibitor	concentrations	in	replicate	populations	at	three	
different	 starting	 concentrations,	 each	with	 or	without	 exposure	 to	
UV	light	to	 increase	mutation	rate.	After	adaptation	to	ten	stepwise	
increases	 in	 fungicide	 concentration,	mutants	 carrying	different	Sdh 
mutations	were	 found	 in	most	populations.	One	population	without	
exposure	to	UV	showed	relatively	 low	levels	of	SDHI	insensitivity	 in	
the	absence	of	target-	site	mutations.	Studies	on	archived	populations	
over	time	showed	the	mutation	rate	was	not	a	limiting	factor	in	UV-	
mutagenized	lines	and	that	the	haplotype	replacement	of	Sdh	variants	
was	governed	by	dose-	dependent	selection	as	the	“selective	window”	
of	the	fungicide	concentration	changed.
2  | MATERIAL AND METHODS
2.1 | Generation of fluxapyroxad- resistant mutants
The	 reference	Z. tritici	 isolate	 IPO323	 (Kema	&	 van	 Silfhout,	 1997)	
was	used	as	the	parental	strain	 in	all	experiments.	For	this,	aliquots	
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of	100	μl	of	 IPO323	spore	suspensions	 (107	spores/ml)	were	plated	
out	onto	60-	mm	petri	dishes	of	YPD	agar	amended	with	0.4%	(v/v)	
DMSO,	 and	 0.04,	 0.06,	 or	 0.08	μg/ml	 of	 fluxapyroxad	 formulated	
as	 an	 emulsifiable	 concentrate	 (62.5	g/L	 EC;	 BASF,	 Ludwigshafen,	
Germany).	Four	YPD	plates	per	fluxapyroxad	concentration	were	in-
oculated,	of	which	two	were	then	exposed	to	300	J/m2	of	UV	 light	
using	 an	 UV	 Crosslinker	 (model:	 XLE-	1000/FB;	 Spectroline,	 New	
York,	NY,	USA).	The	UV	light	exposure	of	300	J/m2	allowed	approxi-
mately	45%	survival.	After	exposure,	 all	 cultures	were	 incubated	at	
21°C	in	the	dark	for	seven	days.
After	 seven	 days’	 incubation,	 spores	were	 harvested	 into	 sterile	
distilled	water	and	quantified	by	haemocytometer	count.	Cultures	with	
at	least	107	spores/ml	were	exposed	to	an	increased	concentration	of	
fungicide.	An	 aliquot	 of	 100	μl	 of	 spore	 suspension	 (107	spores/ml)	
from	each	culture	was	transferred	to	new	YPD	plates	amended	with	
0.4%	(v/v)	DMSO	and	a	twofold	increased	concentration	of	fluxapy-
roxad	and	 left	untreated	or	exposed	to	300	J/m2	of	UV	 light	before	
further	 incubation.	The	 remaining	 spore	 suspension	 of	 each	 culture	
at	 each	 transfer	was	 suspended	 in	80%	 (v/v)	 glycerol	 and	 stored	 at	
80°C	for	further	studies.	Cultures	with	less	than	107	spores/ml	were	
plated	on	 the	 same	 fluxapyroxad	concentration	and	 left	 in	 the	dark	
at	21°C	for	another	generation	of	seven	days	until	they	reached	the	
spore	concentration	needed	to	be	transferred	on	to	a	doubled	fungi-
cide	concentration.	Every	series	of	fungal	cultures	was	kept	separately,	
as	 an	 independent	population,	 labelled	as	 “L”,	 “I,”	 or	 “H”	 for	popula-
tions	initially	exposed	to	a	low	(0.04	μg/ml),	intermediate	(0.06	μg/ml),	
or	high	(0.08	μg/ml)	concentration	of	fluxapyroxad,	respectively,	and	
each	with	 (+)	or	without	 (−)	UV	exposure.	Replicate	populations	can	
be	distinguished	by	the	label	1	or	2	added	to	each	condition	(i.e.,	L−1,	
L−2,	and	L+1,	L+2;	see	Fig.	S1).
After	 ten	 rounds	 of	 selection	 (RS)	 at	 increasing	 concentrations	
of	 fungicide	 (from	 0.04	 to	 20.48	μg/ml,	 0.06	 to	 30.72	μg/ml	 or	
0.08	 to	 40.96	μg/ml),	 fluxapyroxad-	adapted	 mutants	 were	 isolated.	
Populations	were	diluted	 to	produce	 single	 colonies	on	unamended	
YPD	plates,	 and	 twenty	colonies	 from	each	population	were	picked	
and	 subcultured	on	unamended	YPD	 for	 seven	days	 at	21°C	 in	 the	
dark,	and	stored	in	80%	glycerol	(v/v)	at	−80°C	for	further	use.	Mutants	
were	named	in	progressive	number	order	per	population	from	which	
they	came	(e.g.,	from	L−1.1	to	L−1.20).
2.2 | Fungicide sensitivity testing
In	 vitro	 fungicide	 sensitivity	 assays	 were	 carried	 out	 as	 described	
by	Pijls,	Shaw,	and	Parker	 (1994),	see	Supporting	 information.	After	
four	days	of	 fungicide	exposure	at	23°C	 in	 the	dark,	 fungal	 growth	
was	 measured	 using	 absorbance	 readings	 at	 630	nm	 (A630)	 with	
a	 FLUOstar	 OPTIMA	 microplate	 reader	 (BMG	 Labtech	 GmbH,	
Offenberg,	Germany).	Absorbance	was	measured	 in	a	well-	scanning	
mode	with	a	2	×	2	matrix	of	 scanning	points	 set	at	3	mm	diameter.	
Fungicide	sensitivity	was	determined	as	the	concentration,	which	in-
hibited	growth	by	50%	(EC50).	The	EC50	(μg/ml)	values	were	calculated	
using	a	dose–response	curve	(four-	parameter	fit)	using	OPTIMA	soft-
ware	(v2.20OR2).	The	fungicide	sensitivity	test	was	carried	out	twice,	
and	the	progenitor/reference	isolate	IPO323	was	included	as	control.	
The	EC50	values	are	the	average	of	the	two	independent	tests.
To	 determine	 variation	 among	 the	 populations,	 the	 EC50 values 
were	analysed	using	ANOVA	to	compare	the	populations,	taking	ac-
count	 of	 initial	 fungicide	 concentration	 and	 UV	 light	 treatment,	 in	
GenStat	(2014,	17th	edition,	VSN	International©,	Hemel	Hempstead,	
UK).	The	standard	error	of	the	difference	(SED)	based	on	the	residual	
degrees	of	freedom	(df)	from	the	ANOVA	was	used	to	construct	a	least	
significant	difference	(LSD)	at	the	5%	level	of	significance	with	which	
to	compare	relevant	means.
2.3 | Sequencing of the Sdh subunit B, C, or D 
encoding genes
The	binding	site	of	SDHI	fungicides	is	formed	by	Sdh	subunits	B,	C,	
and	D,	and	mutations	conferring	resistance	in	Z. tritici	have	been	previ-
ously	identified	in	all	three	subunits	(Fraaije	et	al.,	2012;	Scalliet	et	al.,	
2012).	 To	 determine	whether	 Sdh	 alterations	were	 associated	with	
SDHI	insensitivity,	two	fluxapyroxad-	insensitive	mutants	with	each	of	
the	highest,	median,	or	lowest	fluxapyroxad	EC50	values	were	selected	
from	each	population	and	their	SdhB,	C, and D	genes	sequenced.
Genomic	DNA	 for	 sequencing	was	 extracted	 and	 quantified	 ac-
cording	Rudd	et	al.	(2010)	from	strains	grown	on	YPD	plates	at	15°C	
in	 the	 dark	 for	 seven	 days.	 PCRs	 were	 carried	 out	 on	 a	 Biometra	
T3000	thermocycler	(Biotron,	Göttingen,	Germany)	in	a	final	volume	
of	50	μl	containing	50	ng	of	fungal	template	DNA.	PCRs	for	amplifi-
cation	of	SdhB or D	contained	0.5	μM	for	each	primer	(Table	S1)	and	
200 μM	dNTP,	1×	Phusion	HF	buffer,	and	1.0	units	of	Phusion	High	
Fidelity	DNA	polymerase	 (New	England	Biolabs,	 Ipswich,	MA,	USA).	
Polymerase	chain	reactions	for	amplification	of	SdhC were 0.2 μM	for	
each	primer	(Table	S1)	and	200	μM	dNTP	and	contained	1×	of	Easy-	A	
reaction	buffer	and	2.5	units	of	Easy-	A	High	Fidelity	PCR	cloning	en-
zyme	(Agilent	Technologies,	Cedar	Creek,	TX,	USA).	Amplification	con-
ditions	were	95°C	for	1	min,	followed	by	30	cycles	at	95°C	for	15	s,	
70°C	(SdhB and D)	or	65°C	(SdhC)	for	30	s,	and	72°C	for	1	min	with	a	
final	DNA	extension	at	72°C	for	5	min.	PCR	products	were	sequenced	
by	MWG	Eurofins	Genomics	GmbH	(Ebersberg,	Germany)	using	spe-
cific	primers	for	each	SdhB,	C, or D	gene	(Table	S1).	Sequences	were	
assembled	 and	 aligned	with	 Geneious	 v.6.1.4	 software	 (Biomatters	
Ltd.,	 Auckland,	 New	 Zealand),	 and	 amino	 acid	 substitutions	 deter-
mined	after	sequence	analysis.
2.4 | SNP detection pyrosequencing assays
To	determine	changes	in	frequency	of	key	DNA	mutations	linked	with	
SDHI	 resistance	 at	 each	 round	 of	 selection,	 six	 populations:	 three	
exposed	to	UV	and	with	a	greater	diversity	of	mutations	 (I+1,	H+1,	
and	H+2),	 and	 the	 others	without	UV	 exposure	 and	with	 fewer	 or	
no	mutations	 (L−1,	 I−1,	and	H+1)	were	 tested	using	SNP	detection	
pyrosequencing	 assays	 using	 the	 PyroMark	 Q96	 system	 (Biotage,	
Uppsala,	 Sweden)	 as	 described	 by	 Carter,	 Cools,	West,	 Shaw,	 and	
Fraaije	(2013)	(see	Supporting	information).	Aliquots	of	10	μl	of	spore	
suspension	 from	 the	 last	 round	 of	 selection,	 and	 stored	 glycerol	
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spore	suspensions	of	previous	RS,	were	plated	out	on	YPD	agar,	and	
incubated	 for	 seven	 days	 at	 15°C	 in	 the	 dark.	DNA	was	 extracted	
from	 each	 population.	Mutants	 carrying	 different	 Sdh	 variants	 and	
the	 reference	 isolate	 IPO323	 were	 used	 as	 positive	 and	 negative	
controls	for	the	SNP	detection	pyrosequencing	assays.	Frequencies	
of	mutations	underlying	SdhB-	H267L,	B-	H267Y,	B-	N225T,	C-	T79I,	
C-	S83G,	C-	H152R,	 and	D-	I50L	were	 estimated	with	 the	PyroMark	
Q96	ID	software	version	2.5.	Frequency	values	are	the	mean	of	two	
technical	 replicate	pyrosequencing	 reactions.	The	detection	 limit	of	
SNP	 detection	 pyrosequencing	 is	 approximately	 3%	 for	 each	 allele	
(Gruber,	Colligan,	&	Wolford,	2002;	Wasson,	Skolnick,	Love-	Gregory,	
&	Permutt,	2002).
2.5 | Effect of fluxapyroxad concentration on the 
selection of SdhC- T79I and C- H152R variants
To	investigate	whether	lineage	replacement	is	mutation-	limited	or	due	
to	alleles	being	favoured	only	at	certain	stages	of	the	selection	regime,	
population	H+1	spore	suspensions	from	RS	3,	4,	or	7	were	regrown	on	
YPD	plates	for	seven	days	at	15°C	in	the	dark	and	subsequently	ex-
posed	to	different	concentrations	of	fluxapyroxad.	For	this,	aliquots	of	
100 μl	of	RS3,	RS4,	or	RS7	spore	suspensions	at	107	spores/ml	were	
plated	out	onto	YPD	plates	amended	with	0.4%	(v/v)	DMSO,	and	0,	
0.32,	0.64,	or	5.12	μg/ml	of	fluxapyroxad.	These	concentrations	cor-
respond	to	the	most	recent	round	of	selection	at	which	these	popula-
tions	were	originally	 selected.	 Inoculated	plates	were	 incubated	 for	
seven	days	at	21°C	in	the	dark,	and	DNA	was	extracted.	Frequencies	
of	SdhC-	T79I	or	C-	H152R	variants	in	these	populations	were	deter-
mined	using	SNP	detection	pyrosequencing	assays.
2.6 | Gene expression studies
Although	mutants	of	population	L−1	were	 less	sensitive	 to	 fluxapy-
roxad,	no	target-	site	mutations	were	found	in	the	SdhB,	C, or D	gene.	
To	 investigate	 whether	 changes	 in	 gene	 expression	 of	 a	 range	 of	
nontarget-	site	resistance	conferring	candidate	genes	were	associated	
with	fluxapyroxad	insensitivity,	we	examined	changes	in	their	mRNA	
levels	 following	 the	 introduction	 of	 the	 fungicide.	 The	 reference	
Z. tritici	 isolate	 IPO323	and	the	fluxapyroxad-	adapted	mutant	L-	1.7,	
with	no	target-	site	mutations	in	the	SdhB,	C, or D	gene,	were	in	vitro	
exposed	 to	 fluxapyroxad	 at	 concentrations	 inhibiting	 growth	 by	 50	
or	 80%	 (EC80),	 and	 changes	 in	 gene	 expression	was	measured	 (see	
Supporting	information).
Relative	 transcript	 abundances	 [relative	 quantities	 (RQ)]	 from	
genes	encoding	SdhB,	C,	or	D,	alternative	oxidase	(AOX),	seven	ABC	
transporters,	 seven	 major	 facilitator	 superfamily	 (MFS)	 drug	 efflux	
transporters,	 seven	 glutathione	 S-	transferase	 (GST),	 and	 β-	tubulin	
were	 determined	 with	 quantitative	 RT-	PCR	 using	 specific	 oligonu-
cleotide	primers	 (Table	S3).	The	 selected	genes	encoding	 transport-
ers	or	GSTs	were	the	seven	most	up-	regulated	genes	 in	 the	Z. tritici 
isolate	IPO323	after	exposure	to	chlorothalonil	or	folpet	in	the	lag	or	
log	phase	of	growth	(Gutierrez-	Alonso,	2015).	The	Aox	gene	was	in-
cluded	because	overexpression	can	confer	 lower	sensitivity	to	other	
fungicides	that	affect	respiration	 (QoI)	 through	nontarget-	site	muta-
tions	(Miguez,	Reeve,	Wood,	&	Hollomon,	2004).
Normalized	relative	quantities	(NRQ)	of	target	genes	were	calcu-
lated	by	the	2−[Δ][Δ]Ct	method	(Pfaffl,	2001),	using	β-	tubulin	as	the	en-
dogenous	control	and	samples	from	the	untreated	IPO323	isolate	as	
calibrator.	NRQ	values	of	selected	target	genes	were	transformed	to	
the	logarithmic	(log2)	scale	and	analysed	using	ANOVA	in	GenStat.	The	
log2(NRQ)	values	were	calculated	assuming	an	efficiency	of	 two	 for	
the	target	and	reference	gene	(Pfaffl,	2001).	Results	are	presented	as	
ratios	to	the	control	treatment,	using	the	log2	(NRQ)	means.
3  | RESULTS
3.1 | Generation of fluxapyroxad- resistant 
Zymoseptoria tritici mutants
Six	fluxapyroxad-	adapted	populations	(L+1,	L+2,	I+1,	I+2,	H+1,	and	H+2)	
derived	from	the	sensitive	Z. tritici	isolate	IPO323	were	obtained	after	
ten	RS	at	increasing	fungicide	concentrations	and	UV	exposure	(Fig.	S1).	
Three	fluxapyroxad-	adapted	populations	(L−1,	I−1	and	H−1)	were	ob-
tained	using	 the	same	series	of	 fungicide	concentrations	but	without	
UV	 light	exposure	 (Fig.	S1).	The	UV	unexposed	populations	L−2,	 I−2,	
and	H−2	stopped	growing	at	week	11,	3,	and	4,	respectively	(Fig.	S1).
Population	 L−1	 was	 obtained	 after	 17	weeks,	 and	 populations	
L+1	and	L+2	were	obtained	after	12	weeks,	using	fluxapyroxad	con-
centrations	from	0.04	to	20.48	μg/ml	 (Fig.	S1A).	Population	I−1	was	
obtained	after	18	weeks,	and	populations	I+1	and	I+2	were	obtained	
after	12	weeks,	using	fluxapyroxad	concentrations	from	0.06	to	30.72	
μg/ml	(Fig.	S1B).	Populations	H−1,	H+1,	and	H+2	were	obtained	after	
12	weeks,	 using	 fluxapyroxad	 concentrations	 from	 0.08	 to	 40.96	 
μg/ml	(Fig.	S1C).	A	total	of	180	fluxapyroxad-	adapted	IPO323	mutants	
were	isolated,	20	from	each	final	population.
3.2 | Sensitivity of fluxapyroxad- resistant mutants 
to SDHIs
Isolates	from	the	fungicide-	adapted	populations	were	less	sensitive	to	
fluxapyroxad	than	the	reference	isolate	IPO323,	which	had	an	average	
EC50	value	of	0.02	μg/ml	in	this	study	(Figure	1a;	Table	S4).	No	signifi-
cant	differences	(p = .2)	were	detected	between	EC50	values	of	the	nine	
populations	studied.	Fluxapyroxad	sensitivity	values	ranged	from	0.29	to	
1.93 μg/ml	(Figure	1a).	There	was	no	strong	association	between	EC50 
values	 and	 exposure	 to	UV	 or	 the	 initial	 fluxapyroxad	 concentration.	
Population	L−1	had	EC50	values	from	0.18	to	0.43	μg/ml	(Figure	1a).
Most	of	the	fluxapyroxad-	resistant	mutants	were	also	less	sensitive	
to	 fluopyram	than	 isolate	 IPO323,	which	has	an	average	EC50 value 
of	0.11	μg/ml	 (Figure	1b;	Table	S4).	There	were	significant	 (p < .001)	
differences	 between	 populations,	with	 a	 clear	 decrease	 in	 sensitiv-
ity	in	seven	populations	(Figure	1b;	L−1,	L+1,	L+2,	I+1,	I+2,	H+1,	and	
H+2),	but	no	change	in	two	non-	UV-	exposed	populations	(Figure	1b;	
I-	1	and	H-	1).	Population	I−1	or	H−1	had	the	 lowest	fluopyram	EC50 
values,	 ranging	 from	0.03	 to	0.20	μg/ml	 (Figure	1b).	The	other	pop-
ulations	ranged	from	0.28	to	>11.0	μg/ml	 (Figure	1b).	Differences	 in	
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fluopyram	sensitivities	between	IPO323-	derived	mutant	populations	
indicate	that	diverse	target-	site	mutations	may	underlie	fluxapyroxad	
resistance	in	the	different	populations	(Scalliet	et	al.,	2012).
The	 IPO323-	derived	 mutants	 were	 also	 less	 sensitive	 to	 car-
boxin,	with	EC50	values	ranging	from	4.73	to	146.5	μg/ml	(Figure	1c)	
compared	 to	 1.36	μg/ml	 for	 the	 parental	 isolate,	 regardless	 of	 the	
treatment	given	to	the	population	from	which	they	came	(Figure	1c;	
Table	S4).	This	lower	sensitivity	to	carboxin	was	expected,	as	fluxapy-
roxad	and	carboxin	are	SDHI	carboxamide	 fungicides	 (FRAC,	2015).	
However,	 there	 were	 significant	 differences	 between	 populations	
(Figure	1c;	p < 0.001).
3.3 | Detection of SdhB, C, and D variants
Based	 on	 the	 results	 of	 the	 fluxapyroxad	 sensitivity	 test,	 57	
fluxapyroxad-	resistant	mutants	were	selected	and	the	genes	encod-
ing	 SdhB,	C,	 and	D	 sequenced	 (Table	1).	Mutations	were	 detected	
in	 51	 of	 these,	 encoding	 seven	 different	 amino	 acid	 substitutions.	
Three	amino	acid	substitutions	were	detected	in	the	SdhB,	exchange	
from	histidine	 to	 tyrosine	or	 leucine	at	 codon	267	 (B-	H267Y/L)	or	
from	asparagine	to	threonine	at	codon	225	(B-	N225T).	Three	other	
amino	acid	substitutions	were	detected	in	the	SdhC,	exchange	from	
threonine	to	isoleucine	at	codon	79	(C-	T79I),	from	serine	to	glycine	
at	 codon	 83	 (C-	S83G),	 or	 from	 histidine	 to	 arginine	 at	 codon	 152	
(C-	H152R).	One	amino	acid	 substitution	was	detected	 in	SdhD,	 an	
exchange	from	isoleucine	to	leucine	at	codon	50	(D-	I50L)	(Figure	2).	
This	 mutation	 (D-	I50L)	 was	 always	 found	 in	 combination	 with	 
B-	N225T	 in	 four	 fluxapyroxad-	resistant	mutants.	Six	 fluxapyroxad-	
resistant	 mutants,	 all	 from	 the	 L−1	 population,	 did	 not	 carry	 any	
amino	acid	 substitutions	 in	 the	 three	Sdh	 subunits	 forming	part	of	
the	SDHI	binding	pocket.	Pyrosequencing	assays	of	the	L−1	popula-
tion	confirmed	the	absence	of	the	target-	site	mutations	found	in	the	
other	populations.	The	distribution	of	substitutions	had	no	obvious	
association	with	 initial	 dose	or	UV	exposure	 (Fig.	 S2).	Most	of	 the	
amino	acid	substitutions	conferred	positive	cross-	resistance	to	fluop-
yram	 and	 carboxin,	 except	 amino	 acid	 substitution	 SdhB-	H267Y,	
which	was	more	 sensitive	 to	 fluopyram	 (Table	1;	Figs.	 S2E	and	H).	
Fluxapyroxad-	insensitive	 mutants	 without	 changes	 in	 the	 SDHI	
binding	pocket	also	showed	lower	sensitivity	to	both	fluopyram	and	
	carboxin	(Table	1;	Figs.	S2	and	C).
3.4 | Dynamics of SDHI resistant alleles in IPO323- 
derived fluxapyroxad- adapted populations
A	continuous	 replacement	of	mutants	 carrying	different	amino	acid	
substitutions	was	measured	in	UV-	exposed	populations	during	subcul-
turing	of	successive	generations	on	agar	with	increasing	fluxapyroxad	
concentrations.	 The	mutation	 underlying	 B-	H267L	was	 detected	 in	
populations	 I+1	 and	H+2	at	 round	of	 selection	 (RS)	5	or	4,	 respec-
tively	(Figure	3).	After	an	initial	detection	of	8%	at	RS5,	the	frequency	
of	B-	H267L	 in	 population	 I+1	 increased	 gradually	 to	 approximately	
80%	at	RS10;	whereas	in	population	H+2,	B-	H267L	increased	up	to	
approximately	8%	at	RS-	7	then	decreased	to	<3%	at	RS10	(Figure	3).	
Mutations	 underlying	 SdhB-	N225T	 and	 SdhD-	I50L	 simultaneously	
were	only	detected	 in	population	H+2	 (Figure	3).	B-	N225T	was	de-
tected	 between	 RS4	 and	 RS9	 at	 low	 frequencies	 (2%–5%),	 and	 at	
RS10,	a	frequency	of	7%	was	measured.	D-	I50L	was	detected	at	RS3	
and	RS6	and	at	RS10	with	an	approximate	allele	frequency	of	14%.	
SdhC-	T79I	was	 detected	 in	 populations	 I+1,	H+1,	 and	H+2	 at	 RS3	
with	an	approximate	allele	frequency	of	7%,	6%,	or	8%,	respectively,	
with	an	 increase	 in	frequency	 (approximately	to	72%,	84%,	or	79%,	
respectively)	at	RS5.	The	frequency	then	decreased	to	<10%	by	RS8	
and	was	undetectable	after	RS9	in	populations	I+1	and	H+1	(Figure	3).	
A	similar	pattern	of	increase	and	later	decrease	in	allele	frequency	of	
C-	T79I	 (to	approximately	15%	at	RS-	9)	was	observed	 in	population	
H+2	 (Figure	3).	SdhC-	H152R	was	detected	 in	populations	 I+1,	H+1,	
and	H+2	at	RS4	(7%),	RS5	(9%)	or	RS-	6	(˂3%),	respectively	(Figure	3).	
The	 C-	H152R	 allele	 frequency	 increased	 to	 approximately	 95%	 in	
population	H	+	1	 after	 RS9,	whereas	 in	 population	H	+	2,	 the	 allele	
frequency	increased	to	71%	at	RS9	then	decreased	to	approximately	
32%	at	RS10.	Similarly,	C-	H152R	increased	to	approximately	40%	at	
RS7	 then	 decreased	 to	 <16%	 at	 RS10	 in	 population	 I+1	 (Figure	3).	
F IGURE  1 Sensitivities	to	fluxapyroxad	(a),	fluopyram	(b),	and	carboxin	(c)	of	Zymoseptoria tritici	IPO323-	derived	populations	after	ten	
increases	of	fungicide	on	YPD	amended	with	0.04	(L−1,	L+1,	L+2),	0.06	(I−1,	I+1,	I+2),	or	0.08	(H−1,	H+1,	H+2)	μg/ml	of	fluxapyroxad	as	starting	
concentration.	Fungicide	concentration	was	increased	twofold	every	round	of	selection.	Populations	L+1,	L	+	2,	I	+	1,	I	+	2,	H	+	1,	and	H	+	2	
were	also	exposed	to	300	J/m2	of	UV	light.	Sensitivity	values	are	the	mean	of	two	independent	experiments.	Star	indicates	the	mean	of	each	
population	consisting	of	20	isolates.	Closed	circles	indicate	values	beyond	the	10th	and	90th	percentiles.	Sensitivity	of	the	parent	IPO323	
isolate	is	the	average	of	ten	technical	replicates
(a)
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SdhC-	S83G	 was	 only	 detected	 in	 population	 I+1	 at	 RS10	 with	 an	
	approximate	allele	frequency	of	14%	(Figure	3).
In	populations	not	exposed	to	UV	light,	no	or	only	a	single	muta-
tion	was	detected.	The	mutation	 resulting	 in	SdhB-	H267Y	was	only	
detected	 in	 populations	 I−1	 and	H−1	 (Figure	4)	 from	 RS6	 and	 RS4	
onwards,	 at	 frequencies	 ˃80%.	 No	 detectable	 levels	 of	 B-	N225T,	 
C-	H267Y/L,	 C-	T79I,	 C-	S83G,	 C-	H152,	 or	 D-	I50L	 alleles	 were	
	measured	in	population	L−1,	confirming	the	Sdh	sequencing	results	of	
the	selected	strains	(Figs.	S2A,B,	and	C).
3.5 | Effect of fluxapyroxad concentration on the 
selection of SdhC- T79I and C- H152R variants in 
population H+1
Changes	in	frequency	of	C-	T79I	or	C-	H152R	depended	on	fungicide	
concentration	during	the	experiment.	When	aliquots	of	the	selected	
populations	were	 regrown	without	 fungicide	amendment	as	 for	 the	
original	DNA	extractions,	the	frequency	of	C-	T79I	and	C-	H152R	re-
mained	comparable	to	that	in	the	parent	population,	with	a	maximum	
difference	of	13%	and	2%,	respectively,	for	RS4.	However,	following	
further	selection	at	the	intermediate	fluxapyroxad	concentrations	of	
0.32	and	0.64	μg/ml,	the	frequency	of	C-	T79I	increased	from	the	low	
parental	 level	 in	RS3	 (Figure	4a),	but	was	unchanged	 from	 its	 inter-
mediate	level	in	samples	from	RS4	and	RS7	(Figure	4a	and	b,	respec-
tively).	At	5.12	μg/ml	fluxapyroxad,	there	was	a	substantial	decrease	
in	frequency	of	C-	T79I	in	samples	taken	from	RS4	and	RS7	(Figure	4b	
and	 c,	 respectively),	 but	 an	 increase	 in	 the	 sample	 taken	 from	RS3	
(Figure	4a).	Frequency	of	C-	H152R	increased	sharply	at	this	concen-
tration	 in	 samples	 from	all	 three	RS,	 confirming	 that	 it	was	 already	
present	at	RS3,	but	undetectable,	below	the	SNP	detection	pyrose-
quencing	threshold.
3.6 | Gene expression
Quantitative	 RT-	PCR	 detected	 a	 low	 but	 significant	 (p < 0.05)	 up-	
regulation	of	genes	encoding	SdhB,	C,	or	D	 in	 response	 to	 fluxapy-
roxad	 treatment	 in	 the	 reference	 isolate	 IPO323	 (Fig.	 S3A,	 Table	
S5).	 In	 the	mutant	L-	1.7,	only	genes	encoding	SdhB	or	D	were	 sig-
nificantly	(p < 0.001)	slightly	up-	regulated	(between	1.1-	and	2.1-	fold	
change;	 Fig.	 S3B	 and	 Table	 S6).	 Reference	 isolate	 IPO323	 and	 the	
L−1.7	showed	similar	AOX	gene	expression	patterns.	Overexpression	
of	 AOX	 was	 only	 significant	 different	 in	 IPO323	 when	 exposed	
F IGURE  2 Location	of	key	amino	acid	substitutions	in	the	sdh	subunits	in	IPO323-derived	fluxapyroxad-	resistant	mutants.	Partial	Sdh	
subunit	sequences	of	Zymoseptoria tritici	(Zt),	Alternaria alternata	(Aa),	Alternaria solani	(As),	Aspergillus oryzae	(Ao),	Corynespora casiicola	(Cc),	
Botrytis cinerea	(Bc),	and	Saccharomyces cerevisiae	(Sc).	Stars	indicate	positions	where	amino	acid	substitutions	were	found.	Conserved	residues	
are	shaded	in	black	or	grey	corresponding	to	100%	or	80%	conservation,	respectively
* * *
Zt 76- P Q I T WY L S A L N 149- G V R H L V W
Aa 65- P Q I T WY A S S L N 138- G L R H L A W
As 65- P Q I T WY A S S L N 138- G L R H L S W
Ao 77- P Q I T WI G S S F H 150- G V R H L V W
Cc 65- P Q I T WY A S S F N 138- G L R H L S W
Bc 77- P Q I P WI MS G L N 150- G L R H L A W
Sc 86- P Q L T WY L S S L H 159- A I R H L I W
SdhB
* *
Zt 222- Y WWN S E E 264- Y R C H T I L
Aa 232- Y WWN Q E E 274- Y R C H T I L
As 233- Y WWN Q E E 275- Y R C H T I L
Ao 204- Y WWN S E E 246- Y R C H T I L
Cc 233- Y WWN Q E E 275- Y R C H T I L
Bc 227- Y WWN S E E 269- Y R C H T I L
Sc 192- Y WWN Q E Q 234- Y R C H T I M
SdhC
*
Zt 46- A R R P I - - - - L
Aa 61- Q R N Q I - - - - L
As 61- Q R T Q I - - - - L
Ao 41- A K K Q I - - - - L
CC 33- Q R Q Q I - - - - L
Bc 60- G R Q S I - - - - L
Sc 28- A K K S L T I P F L
SdhD
TABLE  1 Succinate	dehydrogenase	inhibitor	(SDHI)	sensitivity	profiles	of	IPO323-	derived	fluxapyroxad-	resistant	mutants	carrying	different	
mutations	in	the	SdhB,	C,	or	D	encoding	genes
Strain/Sdh variant
Codon 
sequence 
change N
Fluxapyroxad 
EC50 ± SE
a SD RFb
Fluopyram 
EC50 ± SE SD RF
Carboxin 
EC50 ± SE SD RF
IPO323 None 1 0.02	±	0.004 — — 0.11	±	0.004 — — 1.36 ± 0.02 — —
Nonmutation None 6 0.29 ± 0.05 0.12 12 0.69 ± 0.15 0.38 6 6.77 ± 0.56 1.38 5
B-	H267L CAC	>CTC/CTT 11 1.57	±	0.14 0.45 64 4.29	±	0.34 1.13 40 89.19	±	6.84 22.68 65
B-	H267Y CAC	>	TAC 12 0.76 ± 0.07 0.26 31 0.09 ± 0.01 0.05 0.8 54.23	±	3.68 12.76 40
B-	N225T,	D-	I50L AAC	>	ACC,	
ATT	>	CTT
4 1.31 ± 0.09 0.22 54 0.97 ± 0.07 0.16 9 7.02	±	0.47 1.15 5
C-	T79I ACC	>	ATC 3 0.90 ± 0.02 0.04 37 0.90 ± 0.12 0.21 8 16.82	±	1.74 3.02 12
C-	S83G TCG	>	GGG 6 1.58	±	0.09 0.22 65 >11.10 0.00 >104 15.27 ± 1.70 4.18 11
C-	H152R CAT	>	CGT 15 1.71 ± 0.16 0.63 70 3.94	±	0.50 1.94 37 28.74	±	1.85 7.15 21
aEC50	values	(μg/ml)	are	based	on	the	mean	of	two	independent	experiments.
bResistance	factors	(RFs)	of	laboratory	mutants	carrying	the	same	Sdh	variant	were	calculated	as	the	fold	change	in	mean	EC50	compared	with	the	mean	
EC50	value	of	the	reference	Zymoseptoria tritici	isolate	IPO323.
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F IGURE  3 Frequencies	of	key	SdhB,	C, and D	target-	site	mutations	in	IPO323-	derived	fluxapyroxad-	resistant	populations	during	ten	rounds	
of	selection	(RS)	in	vitro	on	YPD	amended	with	increasing	concentrations	of	fluxapyroxad.	Fluxapyroxad	sensitivity	values	of	IPO323-	derived	
mutant	populations	(A).	Populations	I−1	and	I	+	1	were	exposed	to	0.06	μg/ml	as	starting	fungicide	concentration.	Populations	H−1,	H	+	1,	
and	H	+	2	were	exposed	to	0.08	μg/ml	as	starting	fungicide	concentration.	Fungicide	concentration	was	increased	twofold	at	every	round	of	
selection.	Additionally,	populations	I	+	1,	H	+	1,	and	H	+	2	were	exposed	to	300	J/m2	of	UV	light	at	each	cycle.	Relative	allele	frequency	of	
positive	controls:	B-	H267L=1,	B-	H267Y=1,	B-	N225T=1;	C-	T79I=1,	C-	S83G=1,	C-	H152R=1,	and	D-	I50L=1.	Frequency	values	are	the	mean	of	
two	technical	replicates	between	replicate	pyrosequencing	reactions
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to	 fluxapyroxad	 at	 its	 approximate	 EC50	 and	 EC80	 concentrations	
(Fig.	S3,	Table	S5).
The	gene	encoding	ABCt-	2,	a	putative	ATP-	binding	cassette	trans-
porter	 (Goodwin	 et	al.,	 2011),	 was	 constitutively	 overexpressed	 in	
L−1.7	at	either	the	EC50	(4.6-	fold	change,	p < 0.05)	or	the	EC80	(9.5-	
fold	 change,	p < 0.01)	 fungicide	 concentration	 (Figure	5b,	Table	 S6).	
Genes ABCt-	5	(2.2-	fold	change,	p < 0.05)	and	ABCt-	6	(5.2-	fold	change,	
p < 0.01)	were	only	up-	regulated	 in	 IPO323	 in	 the	presence	of	 flux-
apyroxad	 at	 its	 EC50	 or	 EC80	 concentration,	 respectively	 (Figure	5a,	
Table	S5).
Similarly,	a	glutathione	S-	transferase	encoding	gene	 (GST-	4)	was	
slightly	 but	 significantly	 (p < 0.05)	 up-	regulated	 in	 L-	1.7	 exposed	 to	
fluxapyroxad	 at	 its	 approximate	 EC50	 (1.3-	fold	 change,	 p < 0.05)	 or	
EC80	 (1.9-	fold	 change,	 p < 0.01;	 Fig.	 S4B,	 Table	 S6)	 concentration.	
GST-	4	was	 also	 significantly	 up-	regulated	 (4.0-	fold	 change,	p < 0.05 
or	 10.5-	fold	 change,	 p < 0.01),	 along	 with	 GST-	1	 (2.5-	fold	 change,	
F IGURE  4 Frequency	of	SdhC-	T79I	and	C-	H152R	alleles	in	
H	+	1	populations	grown	for	seven	days	at	various	fluxapyroxad	
concentrations.	Samples	were	taken	from	the	population	after	
three	(a),	four	(b),	and	seven	(c)	rounds	of	selection	(RS).	Cultures	
grew	on	YPD	plates	with	and	without	addition	of	fluxapyroxad	for	
seven	days	at	21°C	in	the	dark.	The	arrows	indicate	the	frequency	
in	the	parent	population	from	which	the	samples	were	taken.	
Frequency	values	are	the	mean	of	two	technical	replicates	between	
replicate	pyrosequencing	reactions.	The	detection	threshold	of	
both	SNP	detection	pyrosequencing	assay	was	3%.	Error	bars	
denote	two	SEM
F IGURE  5 Expression	levels	of	genes	encoding	putative	
ATP-	binding	cassette	transporters	(ABCt)	in	the	reference	
Zymoseptoria tritici	isolate	IPO323	(a)	and	the	laboratory	mutant	
L−1.7	(b)	after	24-	h	exposure	to	their	respective	fluxapyroxad	EC50 
(light	grey)	or	EC80	concentration	(dark	grey),	measured	relative	to	
the	untreated	control	using	quantitative	RT-	PCR.	Mean	of	three	
biological	replicates.	Statistical	significance	for	each	gene	is	marked	
by	asterisks	(*p < .05	or	**p < .01).	See	Table	S5	and	S6	for	the	means	
of	log2	fold-	change	data	for	the	treatments	with	standard	error	of	the	
difference	for	the	comparisons	made
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p < 0.01	at	EC80),	 in	the	reference	isolate	IPO323	in	the	presence	of	
fluxapyroxad	(Fig.	S4A,	Table	S5).
Of	 the	 major	 facilitator	 superfamily	 efflux	 drug	 transporters,	
MSF-	2	 (5.3-	fold	 change,	p < 0.05	or	12.9-	fold	 change,	p < 0.01)	 and	
MSF-	6	 (2.8-	fold	 change,	p < 0.05	or	 8.8-	fold	 change,	p < 0.01)	were	
significantly	up-	regulated	 in	 the	 reference	 isolate	 IPO323	 (Fig.	S5A,	
Table	S5).	In	the	fluxapyroxad-	resistant	mutant	L−1.7,	no	MSF encod-
ing	genes	were	significantly	(p < 0.05)	up-	or	down-	regulated	(Fig.	S5B,	
Table	S6).
4  | DISCUSSION
As	the	SDHI	sensitive	isolate	Z. tritici	IPO323	was	used	as	progenitor	
of	all	populations,	no	external	genotypes	entered	the	mutant	popula-
tions	and	no	genetic	exchange	among	populations	occurred,	so	muta-
tion	was	the	only	source	of	genetic	variability.	Therefore,	selectively	
advantageous	 mutations	 conferred	 steadily	 reducing	 sensitivity	 to	
fluxapyroxad	 over	 time	 in	 all	 nine	 surviving	 populations	 of	Z. tritici. 
Seven	of	the	nine	populations	were	also	less	sensitive	to	fluopyram	or	
carboxin;	two	were	more	sensitive	to	fluopyram.
4.1 | Resistance mechanisms in IPO323- derived 
fluxapyroxad- resistant mutants
Distinct	molecular	mechanisms	conferred	fluxapyroxad	resistance	with	
positive	or	negative	cross-	resistance	 to	 fluopyram.	Mutations	 leading	
to	amino	acid	 substitutions	 in	 the	SDHI	binding	pocket	of	 the	 target	
protein	(SDH)	were	the	most	common.	Mutations	in	the	SdhB	gene	re-
sulted	in	amino	acid	changes	at	codon	225	(N225T)	or	267	(H267Y/L).	
The	 variant	B-	H267L	 conferred	 resistance	 to	 fluxapyroxad,	 carboxin,	
and	 fluopyram,	whereas	B-	H267Y	 increased	 sensitivity	 to	 fluopyram.	
This	 negative	 cross-	resistance	 of	 B-	H267Y	 was	 reported	 before	 for	
Z. tritici	 by	 Fraaije	 et	al.	 (2012)	 and	 Scalliet	 et	al.	 (2012)	 and	 has	 also	
been	 reported	 for	 other	 plant	 pathogens	 (see	 Sierotzki	 &	 Scalliet,	
2013).	In	one	mutant,	two	mutations	leading	to	B-	N225T	and	D-	I50L	
were	found	simultaneously.	This	haplotype	was	associated	with	a	high	
level	 of	 insensitivity	 to	 fluxapyroxad	 and	 lower	 levels	 of	 insensitivity	
to	carboxin	and	 fluopyram	 (Table	1).	Scalliet	et	al.	 (2012)	 reported	B-	
N225H/I	in	laboratory	mutants,	conferring	lower	sensitivity	to	carboxin,	
isopyrazam,	fluopyram,	and	boscalid.	An	equivalent	alteration	in	Botrytis 
cinerea,	 B-	N230I,	 has	 also	been	 linked	with	 SDHI	 resistance	 (Leroux,	
Gredt,	Leroch,	&	Walker,	2010).	Equivalent	mutations	to	D-	I50L	are	not	
known	and	the	precise	role	of	D-	I50L,	alone	or	in	combination	with	B-	
N225T,	in	SDHI	binding	needs	further	studies.	Mutants	carrying	C-	T79I,	
C-	S83G,	or	C-	H152R	are	 insensitive	 to	 fluxapyroxad,	 fluopyram,	 and	
carboxin	(Table	1).	Scalliet	et	al.	(2012)	reported	that	C-	T79I,	C-	H152R,	
or	C-	S83G	variants	can	confer	resistance	to	a	range	of	SDHIs	(i.e.,	car-
boxin,	isopyrazam,	fluopyram,	and	boscalid).	Interestingly,	they	reported	
that	C-	S83G	variants	have	higher	levels	of	resistance	to	fluopyram	than	
variants	C-	T79I	or	C-	H152R.	Similar	results	were	found	in	our	study.
Fluxapyroxad-	insensitive	 isolates	with	no	target-	site	 (SdhB,	C,	or	
D)	alterations	were	also	less	sensitive	to	fluopyram	and	carboxin.	The	
gene	expression	study	indicated	that	overexpression	of	an	ABC	trans-
porter	may	contribute	to	the	phenotype.	The	ABCt-	2	gene,	encoding	
a	putative	Z. tritici	ABC	transporter	 (Goodwin	et	al.,	2011),	was	con-
stitutively	overexpressed	up	to	9.5-	fold	in	the	fluxapyroxad-	resistant	
IPO323	mutant	 L−1.7	 (Figure	5b).	 Similarly,	 Cowen	 et	al.	 (2002)	 re-
ported	overexpression	of	an	ABC	transporter	in	a	mutant	population	
of	C. albicans	grown	for	330	generations	 in	presence	of	 fluconazole,	
without	mutations	in	the	target	protein.	Overexpression	of	ABC	trans-
porters	 was	 also	 detected	 in	 S. cerevisiae	 after	 400	 generations	 at	
increased	concentrations	of	fluconazole	 (Anderson	et	al.,	2003).	The	
overexpression	 of	 the	 ABCt-2	 gene	 indicates	 the	 ability	 of	 Z. tritici 
to	 develop	 resistance	mechanisms	 to	 single-	site	 fungicides	 through	
nontarget-	site	mutations.	A	similar	mechanism	has	also	already	been	
reported	 in	 field	 isolates,	with	 overexpression	 of	MgMfs1,	 encoding	
an	MFS	 transporter,	 conferring	 insensitivity	 to	 different	 fungicides,	
	including	SDHIs	and	azoles	(Omrane	et	al.,	2015).
4.2 | Emergence and evolution of in vitro resistance 
to fluxapyroxad
Emergence	of	amino	acid	substitutions	in	the	Sdh	target	protein	oc-
curred	in	parallel	at	similar	rates	in	the	UV	light	exposed	populations	
I+1,	H+1,	and	H+2	(Figure	3).	Early	in	the	experiment,	the	amino	acid	
substitution	C-	T79I	emerged	in	these	populations	after	adaptation	to	
three	RS	at	increasing	rates	of	fluxapyroxad.	However,	C-	T79I	started	
to	be	outcompeted	by	C-	H152R	after	five	or	six	selection	rounds	in	
populations	H+1	or	H+2,	 respectively.	 Similarly,	 C-	T79I	was	 super-
seded	 by	 B-	H267L	 after	 five	 RS	 in	 population	 I+1.	 Subsequently,	
mutants	carrying	C-	S83G	or	a	double	mutant	(B-	N225T	and	D-	I50L)	
started	to	increase	in	frequency	at	the	end	of	the	experiment	in	popu-
lations	H+1	and	H+2.
The	sequence	of	mutants	carrying	distinct	amino	acid	substitutions	
in	the	SDHI	binding	pocket	of	the	Sdh	complex,	C-	T79I	followed	by	 
C-	H152R	or	B-	H267L,	 indicates	haplotype	replacement	of	Sdh	vari-
ants,	each	having	arisen	independently	from	the	parental	strain,	over	
the	 course	 of	 the	 experiment.	 Clonal	 or	 lineage	 replacement	 takes	
place	 in	 asexual	 populations	where	 mutations	 conferring	 beneficial	
advantages	arise	independently	and	compete	with	others	leading	to	a	
succession	of	genotypes,	each	one	fitter	than	its	immediate	predeces-
sor,	until	the	best	adapted	remains	under	specific	conditions	or	threats	
(Muller,	1932).	Atwood,	Schneider,	and	Ryan	(1951)	reported	a	peri-
odic	replacement	of	strains	(i.e.,	 lineage	replacement)	in	E. coli	popu-
lations	evolving	in	vitro	for	1,000	generations	under	histidine-	limited	
conditions.	They	observed	a	repeated	cycle	of	clonal	strain	substitu-
tions	between	histidine-	required	(h−)	and	histidine-	independent	(h+)	
strains	in	mixed	E. coli	populations	consisting	of	various	ratios	of	h+/
h−,	 inferring	 that	 clonal	 replacement	 took	 place	 approximately	 4.5	
times	 during	 the	 experiment.	 Recently,	Albrecht,	 Jatzwauk,	 Slickers,	
Ehricht,	 and	 Monecke	 (2011)	 reported	 replacement	 of	 methicillin-	
resistant	 Staphylococcus aureus	 (MRSA)	 strains	 in	 human	 patients	
during	a	period	of	11	years	in	German	hospitals.	They	detected	four	
distinct	 MRSA	 strains	with	 their	 frequencies	 fluctuating	 during	 the	
study.	For	example,	a	strain	named	CC22-	MRSA-	IV	was	detected	 in	
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2001	and	 increased	 in	frequency	up	to	approximately	58%	in	2010;	
other	 strains	 such	 CC45-	MRSA-	IV	 decreased	 approximately	 58%	
	frequency	between	2002	and	2010.
Lineage	 replacement	 may	 be	 due	 to	 directly	 mutation-	limited	
evolution,	 in	 which	 the	 fittest	 available	 mutation	 is	 selected	 but	
chance	 mutations	 later	 generate	 a	 fitter	 genotype;	 it	 may	 be	 due	
to	 compensatory	 mutations,	 in	which	 a	 mutation	 may	 have	 arisen	
early	in	the	experiment	but	carries	fitness	penalties	until	compensa-
tory	mutations	emerge;	or	it	may	be	due	to	changing	selection	over	
time,	such	as	the	increasing	fungicide	concentrations	in	the	present	
experiment.	By	 re-	selecting	 the	populations	 from	different	RS	with	
different	 fungicide	doses,	we	show	that	 in	 the	experimental	evolu-
tion	of	resistance	to	SDHI	fungicides	in	Z. tritici,	lineage	replacement	
was	driven	by	changes	 in	fungicide	concentration.	When	the	popu-
lation	from	an	early	round	of	selection	(RS3)	was	exposed	to	a	much	
higher	fungicide	concentration	(5.12	μg	of	fluxapyroxad/ml),	variant	
C-	H152R	was	selected	(Figure	4).	This	shows	that	C-	H152R	was	al-
ready	present	after	three	RS,	but	only	reaches	detectable	frequencies	
under	selection	at	a	high	fungicide	concentration	 (Figures	3	and	4).	
The	 C-	H152R	 mutants	 present	 in	 RS3	 were	 immediately	 selected	
when	transferred	to	higher	fungicide	concentrations,	indicating	that	
no	 further,	 compensatory	 mutations	 were	 needed.	 This	 suggests	
that	mutants	carrying	C-	H152R	are	unable	 to	compete	and	 less	 fit	
than	those	carrying	C-	T79I	at	fungicide	concentrations	<5.12	μg/ml.	
Thus,	mutations	might	emerge	simultaneously	but	a	given	mutation	
will	 only	 increase	 in	 frequency	and	dominate	 the	population	under	
particular	 fungicide	 concentrations	 (Van	den	Bosch,	Paveley,	 Shaw,	
Hobbelen,	&	Oliver,	2011).	In	a	mixed	population	of	wild-	type,	C-	T79I	
and	C-	H152R	variants,	the	optimal	mutant-	selective	window	for	C-	
T79I	is	between	0.32	and	0.64	μg/ml,	whereas	the	mutant-	selective	
window	for	C-	H152R	starts	between	0.64	and	5.12	μg/ml,	under	the	
growth	conditions	used	here.	Further	competition	experiments	could	
define	the	mutant-	selective	windows	more	precisely	both	in	vitro	and	
in	planta.
Selection	by	increasing	fungicide	doses	can	lead	to	sequential	se-
lection	in	a	way	that	constant	doses	would	not.	This	is	because	some	
strains	less	sensitive	or	resistant	to	SDHI	fungicides	appear	to	be	less	
fit	due	to	reduced	SDH	enzyme	activity.	For	example,	C-	H152R	was	
associated	with	 lower	SDH	enzyme	activity	 (47%	of	 covalent	FAD,	
48%	activity	of	MTT/PMS,	and	22%	residual	activity	of	Qo/DCPIP)	
than	the	C-	T79I	variant	(73%	of	covalent	FAD,	106%	activity	of	MTT/
PMS,	and	26%	residual	activity	of	Qo/DCPIP)	 (Scalliet	et	al.,	2012).	
Therefore,	 if	 lower	doses	are	 initially	used,	strains	with	 lower	 levels	
of	resistance	(e.g.,	C-	T79I)	may	initially	be	selected,	after	which	fun-
gicide	dose	could	be	increased	to	regain	some	degree	of	control,	until	
other	 more-	resistant	 strains	 (e.g.,	 C-	H152R,	 C-	S83G,	 or	 B-	H267L)	
are	selected	at	higher	doses.	The	patterns	of	genotype	replacement	
in	our	data	are	consistent	with	the	hypothesis	that	some	alleles	are	
only	 selectively	 advantageous	 in	 restricted	 fungicide	 concentration	
ranges.
If	not	mitigated	by	changes	elsewhere	in	the	genome,	this	fitness	
penalty	could	play	a	key	role	 in	the	development	of	resistance	man-
agement	strategies.	Although	higher	doses	of	SDHIs	can	reduce	SLB	
disease	 symptoms	 slightly	more	 effectively	 (Dooley,	 Shaw,	 Spink,	&	
Kildea,	2016),	using	 lower	doses	of	SDHIs	may	 reduce	selection	 for	
strains	with	higher	resistance	levels.
In	contrast,	in	two	populations,	I−1	and	H−1,	both	exposed	to	ini-
tially	greater	concentrations	of	fluxapyroxad	(0.06	or	0.08	μg/ml)	but	
not	 to	UV	 light,	 only	 a	 single	mutation	 resulting	 in	 amino	 acid	 sub-
stitution	SdhB-	H267Y	arose	after	four	or	five	RS	and	reached	a	high	
frequency,	close	to	fixation	(Figure	3).	Additionally,	in	population	L−1,	
not	exposed	to	UV,	fluxapyroxad	resistance	was	associated	with	over-
expression	of	abct	2	and	no	further	mutations	were	detected	over	the	
course	of	 the	experiment.	This	 suggests	 that	 lineage	 replacement	 is	
less	common	in	a	mutation-	limited	system	and/or	takes	much	longer	
to	develop.
4.3 | Comparison of SDHI resistance development 
in the field and in vitro
Adaptation	 to	 fungicides	 by	 target-	site	 or	 nontarget-	site	 alterations	
has	already	occurred	in	field	populations	of	Z. tritici	(see	Clark,	2006;	
Cools	&	Fraaije,	2013;	Fraaije	et	al.,	2005;	Omrane	et	al.,	2015;	Torriani	
et	al.,	2009).	With	 regard	 to	SDHI	 resistance,	 strains	carrying	amino	
acid	 substitutions	 SdhB-	N225T,	B-	T268I,	 C-	T79N,	C-	W80S,	 and	C-	
N86S,	conferring	low	levels	of	insensitivity,	have	been	reported	in	field	
populations	(FRAC,	2015,	2016).	In	our	evolutionary	study,	resistance	
to	 fluxapyroxad	 emerged	 first	 by	 substitution	of	 tyrosine	by	 isoleu-
cine	 at	 codon	79	of	 SdhC,	which	 is	 the	 same	position	where	T79N	
was	found	in	field	isolates.	The	reported	C-	T79N	field	strains	have	low	
resistance	 factors	 to	different	SDHIs.	 In	our	 study,	 in	vitro	 sensitiv-
ity	assays	indicated	that	the	C-	T79I	variants	had	resistance	factors	of	
37,	8,	and	12	to	fluxapyroxad,	fluopyram,	and	carboxin,	respectively	
(Table	1).	 Interestingly,	one	field	strain	carrying	C-	T79I	was	found	in	
Hampshire	 (UK)	 during	 late	 summer	 in	 2016	 and	 is	 likely	 to	 spread	
further	 in	 the	 absence	 of	 fitness	 costs	 (B.	 A.	 Fraaije,	 unpublished).	
Interestingly,	a	single	field	strain	carrying	B-	N225T	has	been	reported	
(FRAC,	2015).	Mutants	carrying	B-	N225T	and	D-	I50L	showed	higher	
resistance	factors	for	fluxapyroxad	than	C-	T79I	mutants,	but	the	re-
sistance	factors	for	fluopyram	and	carboxin	were	still	low.	Our	studies	
and	Scalliet	et	al.	(2012)	showed	that	several	amino	acid	substitutions	
(e.g.,	B-	H267L,	C-	S83G,	and	C-	H152R)	with	high	resistance	factors	to	
all	SDHIs	might	emerge	in	Z. tritici	field	populations.	Indeed,	C-	H152R	
strains	conferring	high	levels	of	resistance	(RF	>100)	to	bixafen,	pen-
thiopyrad,	and	fluxapyroxad	were	recently	found	in	Z.	trititici	field	pop-
ulations	sampled	 in	 Ireland	(Dooley,	Shaw,	Mehenni-	Ciz	et	al.,	2016)	
and	the	UK	(B.	A.	Fraaije,	unpublished).	Our	study	indicates	that	a	fit-
ness	penalty	(inability	to	compete	with	other	strains	at	lower	fungicide	
concentrations)	might	be	associated	with	this	mutation	which	 in	the	
absence	of	 further	 adaptation	 through	other	 genetic	 chances	might	
delay	the	further	spread	of	this	Sdh	variant	in	field	populations.
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